Gradient Investments’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-61
Closed -$157 1850
2023
Q1
$157 Hold
61
﹤0.01% 1408
2022
Q4
$196 Hold
61
﹤0.01% 1387
2022
Q3
$0 Hold
61
﹤0.01% 1485
2022
Q2
$0 Hold
61
﹤0.01% 1331
2022
Q1
$0 Hold
61
﹤0.01% 1295
2021
Q4
$0 Hold
61
﹤0.01% 1297
2021
Q3
$1K Hold
61
﹤0.01% 1089
2021
Q2
$1K Sell
61
-196
-76% -$2.23K ﹤0.01% 1089
2021
Q1
$4K Buy
257
+196
+321% +$2.27K ﹤0.01% 922
2020
Q4
$0 Hold
61
﹤0.01% 1161
2020
Q3
$0 Hold
61
﹤0.01% 1193
2020
Q2
$0 Hold
61
﹤0.01% 1156
2020
Q1
$0 Buy
+61
New +$554 ﹤0.01% 1190

Other funds holding OGI

Gradient Investments's OGI Position: Q2 2023 in Review

Gradient Investments sold out of Organigram Holdings (OGI) in Q2 2023, closing a stake of 61 shares — an estimated $157 sold.

Gradient Investments first reported a position in OGI in Q1 2020 and held it in 13 quarters. The position peaked at $4K in Q1 2021. 85 funds tracked by Wall St. Rank hold OGI as of Q2 2023.

  • Gradient Investments reported no remaining Organigram Holdings position as of Q2 2023 after selling out during the quarter.
  • Gradient Investments sold 61 Organigram Holdings shares in Q2 2023, an estimated $157.
  • Gradient Investments first reported a position in Organigram Holdings in Q1 2020 and held it in 13 quarters.
  • Gradient Investments's Organigram Holdings position peaked at $4K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2023.

Based on Gradient Investments's 13F filing for Q2 2023, filed 11 Jul 2023.